Assignee
VERACYTE INC
US·16 granted patents·41 pending applications·150 citations·filing 2012–2025
Top patents by PatentIndex Score
57 records- 0198US10731223B2Algorithms for disease diagnosticsVERACYTE INC·Filed 2017·Granted Aug 4, 2020·26 cites·17 claims
- 0298US10236078B2Methods for processing or analyzing a sample of thyroid tissueVERACYTE INC·Filed 2017·Granted Mar 19, 2019·16 cites·29 claims
- 0398US9856537B2Algorithms for disease diagnosticsVERACYTE INC·Filed 2016·Granted Jan 2, 2018·27 cites·24 claims
- 0497US10114924B2Methods for processing or analyzing sample of thyroid tissueVERACYTE INC·Filed 2017·Granted Oct 30, 2018·24 cites·30 claims
- 0595US12110554B2Methods for classification of tissue samples as positive or negative for cancerVERACYTE INC·Filed 2021·Granted Oct 8, 2024·3 cites·21 claims
- 0695US10672504B2Algorithms for disease diagnosticsVERACYTE INC·Filed 2019·Granted Jun 2, 2020·15 cites·21 claims
- 0795US10446272B2Methods and compositions for classification of samplesVERACYTE INC·Filed 2017·Granted Oct 15, 2019·15 cites·22 claims
- 0892US12305238B2Methods for treatment of thyroid cancerVERACYTE INC·Filed 2024·Granted May 20, 2025·0 cites·28 claims
- 0990US10934587B2Methods and compositions for diagnosis of thyroid conditionsVERACYTE INC·Filed 2014·Granted Mar 2, 2021·6 cites·17 claims
- 1089US11217329B1Methods and systems for determining biological sample integrityVERACYTE INC·Filed 2018·Granted Jan 4, 2022·7 cites·19 claims
- 1188US12297503B2Methods for classification of tissue samples as positive or negative for cancerVERACYTE INC·Filed 2024·Granted May 13, 2025·0 cites·30 claims
- 1285US10526655B2Methods for evaluating COPD statusVERACYTE INC·Filed 2014·Granted Jan 7, 2020·9 cites·12 claims
- 1385US2025037869A1Methods and compositions for classification of samplesVERACYTE INC·Filed 2024·Application pending·0 cites
- 1484US11639527B2Methods for nucleic acid sequencingVERACYTE INC·Filed 2021·Granted May 2, 2023·1 cites·16 claims
- 1583US11976329B2Methods and systems for detecting usual interstitial pneumoniaVERACYTE INC·Filed 2021·Granted May 7, 2024·1 cites·20 claims
- 1679US12534763B2Systems and methods of diagnosing idiopathic pulmonary fibrosisVERACYTE INC·Filed 2023·Granted Jan 27, 2026·0 cites·25 claims
- 1779US2025171854A1Genetic signatures to predict prostate cancer metastasis and identify tumor aggressivenessVERACYTE INC·Filed 2024·Application pending·0 cites
- 1874US2023272476A1Nano46 genes and methods to predict breast cancer outcomeVERACYTE INC·Filed 2022·Application pending·0 cites
- 1974US2024417800A1Use of a genetic signature diagnostically to evaluate treatment strategies for prostate cancerVERACYTE INC·Filed 2024·Application pending·0 cites
- 2074US2020202974A1Algorithms for disease diagnosticsVERACYTE INC·Filed 2020·Application pending·0 cites
- 2173US2019172551A1Algorithms for disease diagnosticsVERACYTE INC·Filed 2019·Application pending·0 cites
- 2272US2019080047A1Algorithms for disease diagnosticsVERACYTE INC·Filed 2018·Application pending·0 cites
- 2372US2020176078A1Algorithms for disease diagnosticsVERACYTE INC·Filed 2020·Application pending·0 cites
- 2469US2021332431A1Methods for nucleic acid sequencingVERACYTE INC·Filed 2021·Application pending·0 cites
- 2567US2014378425A1Biomarkers for diagnosis of lung diseases and methods of use thereofVERACYTE INC·Filed 2014·Application pending·0 cites
- 2667US2020143944A1Methods and compositions for classification of samplesVERACYTE INC·Filed 2019·Application pending·0 cites
- 2766US2021040559A1Biomarkers for diagnosis of lung diseases and methods of use thereofVERACYTE INC·Filed 2020·Application pending·0 cites
- 2865US2017145513A1Methods and compositions of molecular profiling for disease diagnosticsVERACYTE INC·Filed 2016·Application pending·0 cites
- 2964US2021079471A1Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional dataVERACYTE INC·Filed 2020·Application pending·0 cites
- 3064US2025308632A1Prognosis and treatment of molecular subtypes of prostate cancerVERACYTE INC·Filed 2023·Application pending·0 cites
- 3164US2016312307A1Methods and compositions of molecular profiling for disease diagnosticsVERACYTE INC·Filed 2016·Application pending·0 cites
- 3264US2016312308A1Methods and compositions of molecular profiling for disease diagnosticsVERACYTE INC·Filed 2016·Application pending·0 cites
- 3364US2021040562A1Methods for evaluating lung cancer statusVERACYTE INC·Filed 2020·Application pending·0 cites
- 3464US2016312306A1Methods and compositions of molecular profiling for disease diagnosticsVERACYTE INC·Filed 2016·Application pending·0 cites
- 3564US2016312305A1Methods and compositions of molecular profiling for disease diagnosticsVERACYTE INC·Filed 2016·Application pending·0 cites
- 3664US2021355524A1Methods for Nucleic Acid SequencingVERACYTE INC·Filed 2021·Application pending·0 cites
- 3763US2020332368A1Nano46 genes and methods to predict breast cancer outcomeVERACYTE INC·Filed 2020·Application pending·0 cites
- 3863US2014349864A1Methods and compositions of molecular profiling for disease diagnosticsVERACYTE INC·Filed 2013·Application pending·0 cites
- 3962US2024071622A1Clinical classifiers and genomic classifiers and uses thereofVERACYTE INC·Filed 2023·Application pending·0 cites
- 4061US2017247759A1Biomarkers for diagnosis of lung diseases and methods of use thereofVERACYTE INC·Filed 2016·Application pending·0 cites
- 4161US2024209449A1Methods and systems to identify a lung disorderVERACYTE INC·Filed 2023·Application pending·0 cites
- 4260US2013150257A1Methods and compositions for sample identificationVERACYTE INC·Filed 2012·Application pending·0 cites
- 4357US2017335396A1Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional dataVERACYTE INC·Filed 2015·Application pending·0 cites
- 4456US2025263795A1Methods for classification of tissue samples as positive or negative for cancerVERACYTE INC·Filed 2025·Application pending·0 cites
- 4556US2022148677A1Methods and systems for detecting genetic fusions to identify a lung disorderVERACYTE INC·Filed 2021·Application pending·0 cites
- 4655US12297505B2Algorithms for disease diagnosticsVERACYTE INC·Filed 2021·Granted May 13, 2025·0 cites·25 claims
- 4753US2020232046A1Genomic sequencing classifierVERACYTE INC·Filed 2020·Application pending·0 cites
- 4851US2025305051A1Systems and methods of diagnosing idiopathic pulmonary fibrosisVERACYTE INC·Filed 2025·Application pending·0 cites
- 4951US2022084632A1Clinical classfiers and genomic classifiers and uses thereofVERACYTE INC·Filed 2020·Application pending·0 cites
- 5050US2013231258A1Methods and Compositions for Classification of SamplesVERACYTE INC·Filed 2012·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when VERACYTE INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →